Does TACROLIMUS Cause Left ventricular hypertrophy? 135 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Left ventricular hypertrophy have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
135
Reports of Left ventricular hypertrophy with TACROLIMUS
0.2%
of all TACROLIMUS reports
4
Deaths
75
Hospitalizations
How Dangerous Is Left ventricular hypertrophy From TACROLIMUS?
Of the 135 reports, 4 (3.0%) resulted in death, 75 (55.6%) required hospitalization, and 11 (8.1%) were considered life-threatening.
Is Left ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Left ventricular hypertrophy?
AMLODIPINE (158)
CLOZAPINE (149)
FUROSEMIDE (128)
PANTOPRAZOLE (117)
BISOPROLOL (114)
SACUBITRIL\VALSARTAN (105)
ASPIRIN (104)
ROSUVASTATIN (94)
CARVEDILOL (87)
ALBUTEROL (86)
Which TACROLIMUS Alternatives Have Lower Left ventricular hypertrophy Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB